CYDY - CytoDyn: Matching Leronlimab Up Against Other COVID-19 Therapeutics
As the worldwide death toll surpasses 250K, scientists from around the world are in a race to discover and test effective therapeutics to treat COVID-19. Researchers are either attempting to try an already approved drug used in another indication, test a pipeline candidate or discover a novel therapeutic. Once a researcher has determined that the therapy/drug could be effective for COVID-19 patients, they have to determine how the candidate will be implemented in the treatment paradigm. Will it be for mild-to-moderate patients? Will it be used as a third-line therapy for critical patients? Is it